Drug Shortage Report for CABAZITAXEL FOR INJECTION

Last updated on 2022-02-08 History
Report ID 152611
Drug Identification Number 02487500
Brand name CABAZITAXEL FOR INJECTION
Common or Proper name CABAZITAXEL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CABAZITAXEL
Strength(s) 60MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 60MG/6ML 1LIVI
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-02-07
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-02-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-02-08 English Compare
v5 2022-02-01 French Compare
v4 2022-02-01 English Compare
v3 2022-01-25 English Compare
v2 2022-01-12 French Compare
v1 2022-01-12 English Compare

Showing 1 to 6 of 6